Ig. Finlay et al., THE EFFECT OF TOPICAL 0.75-PERCENT METRONIDAZOLE GEL ON MALODOROUS CUTANEOUS ULCERS, Journal of pain and symptom management, 11(3), 1996, pp. 158-162
The unpleasant smell of infected fungating tumors and benign cutaneous
ulcers is a distressing clinical problem, known to be associated with
anaerobic infection. Topical metronidazole 0.8% get has been shown to
decrease smell from fungating malodorous tumors. This study was condu
cted to assess prospectively the subjective and bacteriological respon
se to 0.75% metronidazole gel to decrease smell from these lesions and
to assess whether bacterial contamination of the tubes of gel occurs
during use. Forty-seven patients with benign or malignant cutaneous le
sions associated with a foul smell were assessed for smell, pain, appe
arance, and bacteriological profile before entry and at 7 and 14 days.
Forty-one (95%) of the 43 patients assessed at 14 days reported decre
ased smell. Anaerobic infection was initially found in 25 (53%) of pat
ients and was eliminated in 21 (84%) of these. At review after 7 days,
patients reported less pain from the lesions. Discharge and associate
d cellulitis were also observed to decrease significantly.